Views
1 year ago

2009 Scientific Report

  • Text
  • Institute
  • Scientific
  • Molecular
  • Laboratory
  • Tumor
  • Signaling
  • Michigan
  • Biology

Van Andel Research

Van Andel Research Institute | Scientific Report External Research Collaborators Donald Bottaro and Benedetta Peruzzi, National Cancer Institute, Bethesda, Maryland Sandra Cottingham, Spectrum Health Hospital, Grand Rapids, Michigan Sherri Davies and Matthew Ellis, Washington University, St. Louis, Missouri Francesco DeMayo, Baylor College of Medicine, Houston, Texas Ermanno Gherardi, MRC Center, Cambridge, England Beatrice Knudsen, Fred Hutchinson Cancer Research Center, Seattle, Washington Stephanie Kermorgant, Queen Mary and Westfield College, University of London, U.K. Ernest Lengyel and Ravi Salgia, University of Chicago, Illinois Kangda Liu, Zhongshan Hospital, Fudan University, P.R.C. Patricia LoRusso and Fred Miller, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan Benjamin Neel, University of Toronto, Ontario, Canada Ilan Tsarfaty, Tel Aviv University, Israel Robert Wondergem, East Tennessee State University, Johnson City Recent Publications Gao, C.-F., Q. Xie, Y.-W. Zhang, Y. Su, P. Zhao, B. Cao, K. Furge, J. Sun, K. Rex, T. Osgood, et al. 2009. Therapeutic potential of hepatocyte growth factor/scatter factor neutralizing antibodies: inhibition of tumor growth in both authcrine and paracrine hepatocyte growth factor/scatter factor:c-Met–driven models of leiomyosarcoma. Molecular Cancer Therapeutics 8(10): 2803–2810. Graveel, C.R., J.D. DeGroot, Y. Su, J.M. Koeman, K. Dykema, S. Leung, J. Snider, S.R. Davies, P.J. Swiatek, S. Cottingham, et al. 2009. Met induces diverse breast carcinomas in mice and is associated with human basal breast cancer. Proceedings of the National Academy of Sciences U.S.A. 106(31): 12909–12914. Kort, Eric J., Nigel Paneth, and George F. Vande Woude. 2009. The decline in U.S. cancer mortality in people born since 1925. Cancer Research 69(16): 6500–6505. VanBrocklin, Matthew W., James P. Robinson, Todd Whitwam, Adam R. Guibeault, Julie Koeman, Pamela J. Swiatek, George F. Vande Woude, Joseph D. Khoury, and Sheri L. Holmen. 2009. Met amplification and tumor progression in Cdkn2a-deficient melanocytes. Pigment Cell & Melanoma Research 22(4): 454–460. Standing, from left: Zhang, Nelson, Essenburg, Graveel, Staal, Su, DeGroot, Thompson, Haak, Xie, Gao; seated, from left: Holman, Vande Woude, Kaufman 58

VARI | 2009 Craig P. Webb, Ph.D. Program for Translational Medicine Dr. Webb received his Ph.D. in cell biology from the University of East Anglia, England, in 1995. He then served as a postdoctoral fellow in the laboratory of George Vande Woude in the Molecular Oncology Section of the Advanced BioScience Laboratories–Basic Research Program at the National Cancer Institute, Frederick Cancer Research and Development Center, Maryland (1995–1999). Dr. Webb joined VARI as a Scientific Investigator in October 1999; he now oversees the Program for Translational Medicine as Senior Scientific Investigator. Staff Students Visiting Scentist David Cherba, Ph.D. Jessica Hessler, Ph.D. Jeremy Miller, Ph.D. David Monsma, Ph.D. Emily Eugster, M.S. Patrick Richardson, M.S. Sujata Srikanth, M.Phil. Dawna Dylewski, B.S. Brian Hillary, B.A. Hailey Jahn, B.S. Marcy Ross, B.S. Stephanie Scott, B.S. Theresa Wood, B.A. Katherine Koehler Nicole Beuschel Orrie Close Bess Connors Molly Dobb Phillip Dumas Sean Vance Richard Leach, M.D. 59

Publications by Year